Strategies and challenges in the detection of clonal hematopoiesis:current advances and future perspectivesOA
Clonal hematopoiesis(CH)is the clonal expansion of hematopoietic stem and progenitor cell lineages carrying acquired somatic mutations,a common feature of hematopoietic aging.Its clinical relevance extends beyond hematologic malignancy risk to inflammation-linked comorbidities and emerging implications for cancer therapy response.CH detection faces a depth-dependent trade-off:cohort-scale whole-genome and whole-exome sequencing often miss small clones,whereas ultra-deep targeted panels increase exposure to technical artifacts that mimic low-frequency variants.We summarize approaches to stabilize low-variant allele fraction calls,including unique molecular identifier(UMI)-based error suppression,background modeling with panels of normals,and consensus calling across complementary variant callers.We also note how deep learning can improve artifact discrimination and variant prioritization when rule-based filters become brittle.Finally,we outline an interpretation framework integrating orthogonal evidence,including non-coding risk variants,routine clinical measures,and proteomic/metabolomic readouts,and we emphasize the need for better harmonization of detection and reporting standards.
Ya-Bin Liu;Yi-Yang Xu;Si-Zhe Yang;Huan Song;Bo Jiao;Yun Tan
Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaShanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaShanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaDepartment of Clinical Laboratory Medicine,Shanghai Pulmonary Hospital,Tongji University School of Medicine,Shanghai 200082,ChinaShanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaShanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
医药卫生
Clonal hematopoiesis(CH)Low-frequency variantDeep learning
《LabMed Discovery》 2026 (1)
P.40-43,4
financially supported by the National Natural Science Foundation of China(Nos.82370154,82100158,and 82303072)the Natural Science Foundation of Shanghai,China(Nos.24QA2705100,21ZR1480900,21YF1427900,and 23YF1435600)the Noncommunicable Chronic Diseases-National Science and Technology Major Project,China(No.2023ZD0500700).
评论